Breast carcinoma epithelial cells express a very low-density lipoprotein receptor variant lacking the O-linked glycosylation domain encoded by exon 16, but with full binding activity for serine proteinase/serpin complexes and M(r)-40,000 receptor-associated protein

European Journal of Biochemistry

Volumn 248, Issue 2, 1997, Pages 583-591

  Martensen, Pia M ^a   Oka, Kazuhiro ^b   Christensen, Lise ^c   Rettenberger, Peter M ^a   Petersen, Helle H ^a   Christensen, Anni ^a   Chan, Lawrence ^b   Heegaard, Christian W ^a   Andreasen, Peter A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c University of Copenhagen   (Denmark)

Author keywords

40 kDa receptor associated protein; Breast carcinoma; Plasminogen activator inhibitor 1; Urokinase type plasminogen activator; Very low density lipoprotein receptor

Indexed keywords

LIPOPROTEIN RECEPTOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BREAST CARCINOMA; CELL CULTURE; CELL LINE; CONTROLLED STUDY; ENDOCYTOSIS; EPITHELIUM CELL; EXON; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN VARIANT;

ANIMALIA;

EID: 0030931964     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00583.x     Document Type: Article

References (48)

1. Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H. & Russell, D. W. (1989) Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme, J. Biol. Chem. 264, 8222-8229.
2. Andreasen, P. A., Sottrup-Jensen, L., Kjøller, L., Nykjær, A., Moestrup, S. K., Petersen, C. M. & Gliemann, J. (1994) Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes, FEBS Lett. 338, 239-245.
3. Andreasen, P. A., Kjøller, L., Christensen, L. & Duffy, M. J. (1997) The urokinase-type plasminogen activator system in cancer metastasis. A review, Int. J. Cancer, in the press.
4. Argraves, K. M.. Battey, F. D., MacCalman, C. D., McCrae, K. R., Gåfvels, M., Kozarsky, K. F., Chappell, D. A., Strauss, J. F. & Strickland, D. K. (1995) The very low-density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes, J. Biol. Chem. 270, 26550-26557.
5. Argraves, K. M., MacCalman, C. D., Strauss, J. F. III, Fallon, J. T., Harpel, P. C. & Strickland, D. K. (1996) The very low-density lipoprotein receptor mediates the uptake and degradation of the atherogenic lipoprotein, lp(a), Fibrinolysis 10, Suppl. 3, 5.
6. Battey, F. D., Gåfvels, M. K., Fitzgerald, D. J., Argraves, W. S., Chappell, D. A., Strauss, J. F. I. & Strickland, D. K. (1994) The 39-kDa receptor-associated protein regulates ligand binding by the very low-density lipoprotein receptor, J. Biol. Chem. 269, 23268-23273.
7. Boast, S., Mantia, G. L., Lania, L. & Blasi, F. (1983) High efficiency of replication and expression of foreign genes in SV40-transformed human fibroblasts, EMBO J. 2, 2327-2331.
8. Bu, G., Geuze, H. J., Strous, G. J. & Schwartz, A. L. (1995) 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein, EMBO J. 14, 2269-2280.
9. Bu, G. & Rennke, S. (1996) Receptor-associated protein is a folding chaperone for low-density lipoprotein receptor-related protein, J. Biol. Chem. 271, 22218-22224.
10. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162, 156-159.
11. 2-macroglobulin receptor in human breast carcinomas, Int. J. Cancer 66, 441-452.
12. Danø, K., Andreasen, P. A., Grøndahl-Hansen, J., Kristensen, P., Nielsen, L. S. & Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer, Adv. Cancer Res. 44, 139-266.
13. Davis, C. G., Elhammer, A., Russell, D. W., Schneider, W. J., Kornfeld, S., Brown, M. S. & Goldstein, J. L. (1986) Deletion of clustered O-linked carbohydrates does not impair function of low-density lipoprotein receptor in transfected fibroblasts, J. Biol. Chem. 261, 2828-2838.
14. 2MR/LRP): Binding and endocytosis of fluid phase and membrane-associated ligands, Ann. N.Y. Acad. Sci. 737, 20-38.
15. Gåfvels, M. E., Caird, M., Britt, D., Jackson, C. L., Patterson, D. & Strauss, J. F. III (1993) Cloning of a cDNA encoding a putative human very low-density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23, Somatic Cell Mol. Genet, 19, 557-569.
16. Heegaard, C. W., Simonsen, A. C. W., Oka, K., Kjøller, L., Christensen, A., Madsen, B., Ellgaard, L., Chan, L. & Andreasen, P. A. (1995) Very low-density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex, J. Biol. Chem. 270, 20855-20861.
17. Jensen, P. H., Christensen, E. I., Ebbesen, P., Gliemann, J. & Andreasen, P. A. (1990) Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells, Cell Regul. 1, 1043-1056.
18. Jingami, H. & Yamamoto, T. (1995) The VLDL receptor: wayward brother of the LDL receptor, Curr. Opin. Lipidol. 6, 104-108.
19. Jokinen, E. V., Landschulz, K. T., Wyne, K. L., Ho, Y. K., Frykman, P. K. & Hobbs, H. H. (1994) Regulation of the very low-density lipoprotein receptor by thyroid hormone in rat skeletal muscle, J. Biol. Chem. 269, 26411-26418.
20. Kajinami, K., Mabuchi, H., Itoh, H., Michishita, I., Takeda, M., Wakasugi, T., Koizumi, J. & Takeda, R. (1988) New variant of low-density lipoprotein receptor gene: FH-Tonami, Arteriosclerosis 8, 187-192.
21. 2-macroglobulin receptor/low density lipoprotein receptor-related protein, Eur. J. Biochem. 248, 270-281.
22. Kim, D. H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H.-J., Suzuki, H., Kondo, H., Saeki, S. & Yamamoto, T. (1996) Human Apolipoprotein E receptor 2: A novel lipoprotein receptor of the low-density lipoprotein receptor family predominantly expressed in brain, J. Biol. Chem. 271, 8373-8380.
23. Kingslay, D. M. & Krieger, M. (1984) Receptor-mediated endocytosis of low-density lipoprotein: Somatic cell mutants define multiple genes required for expression of surface-receptor activity, Proc. Natl Acad. Sci. USA 81, 5454-5458.
24. 2-macroglobulin receptor and urokinase receptor expression, Mol. Cell. Endocrinol. 109, 209-217.
25. Kobayashi, K., Oka, K., Forte, T., Ishida, B., Teng, B., Ishimura-Oka, K., Nakamuta, M. & Chan, L. (1996) Reversal of hypercholesterolemia in low-density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low-density lipoprotein receptor, J. Biol. Chem. 271, 6852-6860.
26. Koivisto, P. V. I., Koivisto, U.-M., Kovanen, P. T., Gylling, H., Miettinen, T. A. & Kontula, K. (1993) Deletion of exon 15 of the LDL receptor gene is associated with a mild form of familial hypercholesterolemia, Aeterioscler. Thromb. 13, 1680-1688.
27. Mignatti, P. & Rifkin, D. B. (1993) Biology and biochemistry of proteinases on tumor invasion, Physiol. Rev. 73, 161-195.
28. 2-macroglobulin receptor and epithelial glycoprotein-330. Two giant receptors mediating endocytosis of multiple ligands, Biochem. Biophys. Acta 1197, 197-213.
29. Mokuno, H., Brady, S., Kotite, L., Herz, J. & Havel, R. J. (1994) Effect of the 39-kDa receptor-associated protein on hepatic uptake and endocytosis of chylomicron remnants and low-density lipoproteins in the rat, J. Biol. Chem. 269, 13238-13243.
30. Multhaupt, H. A. B., Gåfvels, M. E., Kariko, K., Jin, H., Arenas-Elliot, C., Goldman, B. I., Strauss, J. F. III, Angelin, B., Warhol, M. J. & McCrae, K. R. (1996) Expression of very low-density lipoprotein receptor in the vascular wall. Analysis of human tissue by in situ hybridization and immunohistochemistry, Am. J. Pathol. 148, 1985-1997.
31. Munch, M., Heegaard, C., Jensen, P. H. & Andreasen, P. A. (1991) Type-1 inhibitor of plasminogen activators: Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies, FEBS Lett. 295, 102-106.
32. Munch, M., Heegaard, C. W. & Andreasen, P. A. (1993) Interconversion between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor, Biochim. Biophys. Acta 1202, 29-37.
33. Nielsen, B. S., Sehested, M., Timshel, S., Pyke, C. & Danø, K. (1996) Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer, Lab. Invest. 74, 168-177.
34. Novak, S., Hiesberger, T., Schneider, W. J. & Nimpf, J. (1996) A new low-density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse, J. Biol. Chem. 271, 11732-11736.
35. 2-macroglobulin receptor/LDL receptor-related protein binds urokinase-plasminogen activator inhibitor type-1 complex, J. Biol. Chem. 267, 14543-14546.
36. Oka, K., Ishimura-Oka, K., Chu, M.-J., Sullivan, M., Krushkal, J., Li, W.-H. & Chang, L. (1994a) Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor, Eur. J. Biochem. 224, 975-982.
37. Oka, K., Tzung, K. W., Sullivan, M., Lindsay, E., Baldini, A. & Chan, L. (1994b) Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and locallization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization, Genomics 20, 298-300.
38. Reilly, D., Christensen, L., Duch, M., Nolan, N., Duffy, M. J. & Andreasen, P. A. (1992) Type-1 plasminogen activator inhibitor in human breast carcinomas, Int. J. Cancer 50, 208-214.
39. Sakai, J., Hoshino, A., Takahashi, S., Miura, Y., Ishii, H., Suzuki, H., Kawarabayasi, Y. & Yamamoto, T. (1994) Structure, chromosome location, and expression of the human very low-density lipoprotein receptor gene, J. Biol. Chem. 269, 2173-2182.
40. Schmid, E., Schiller, D. L., Grund, C. Stadler, J. & Franke, W. W. (1983) Tissue type-specific expression of intermediate filament proteins in a cultured epithelial cell line from bovine mammary gland, J. Cell. Biol. 96, 37-50.
41. r 40000 receptor associated protein, FEBS Lett. 354, 279-283.
42. Strickland, D. K., Kounnas, M. Z., Williams, S. E. & Argraves, W. S. (1994) LDL receptor-related protein (LRP): A multiligand receptor, Fibrinolysis 8, Suppl. 1, 204-215.
43. Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J. & Yamamoto, T. (1992) Rabbit very low-density lipoprotein receptor: A low density receptor-like protein with distinct ligand specificity, Proc. Natl Acad. Sci. USA 89, 9252-9256.
44. Takahashi, S., Suzuki, J., Kohno, M., Oida, K., Tamai, T., Miyabo, S., Yamamoto, T. & Nakai, T. (1995) Enhancement of the binding of triglyceride-rich lipoproteins to the very low-density lipoprotein receptor E and lipoprotein lipase, J. Biol. Chem. 270, 15747-15754.
45. Webb, J. C., Patel, D. D., Jones, M. D., Knight, B. L. & Soutar, A. K. (1994) Characterization and tissue-specific expression of the human 'very low-density lipoprotein (VLDL) receptor' mRNA, Hum. Mol. Gen. 3, 531-537.
46. Willnow, T. E., Armstrong, S. A., Hammer, R. E. & Herz, J. (1995) Functional expression of low-density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo, Proc. Natl Acad. Sci. USA 92, 4537-4541.
47. Wittmaack, F. M., Gåfvels, M. E., Bronner, M., Matsuo, H., McCrae, K. R., Tomaszewski, J. E., Robinson, S. L., Strickland, D. K. & Strauss, J. F. (1995) Localization and regulation of the human very low-density lipoprotein/apolipoprotein E receptor: Trophoblast expression predicts a role for the receptor in placental lipid transport, Endocrinology 136, 340-348.
48. Wyne, K. L., Pathak, R. K., Seabra, M. C. & Hobbs, H. H. (1996) Expression of the VLDL receptor in endothelial cells, Arterioscler. Thromb. Vasc. Biol. 16, 407-415.